Your session is about to expire
← Back to Search
Radiation Therapy
SABR for Metastatic Cancer
N/A
Recruiting
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
All sites of disease can be safely treated on a preliminary radiation plan
Age 18 or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time from randomization to death from any cause, patients followed for 5 years
Awards & highlights
Study Summary
This trial is testing a new cancer treatment called SABR to see if it's better than the current standard of care. It will involve patients with cancer that has spread to multiple parts of their body.
Who is the study for?
This trial is for adults with cancer that has spread to many places in the body, who can safely receive radiation therapy. They should not be planning any systemic treatments like chemotherapy for 3 months and must have a life expectancy of at least 6 months. Pregnant women or those with serious health issues related to radiotherapy are excluded.Check my eligibility
What is being tested?
The ARREST-2 trial compares standard cancer care (Arm 1) with Stereotactic Ablative Radiotherapy (SABR) treatment (Arm 2). It aims to see if SABR improves survival, slows disease progression, enhances quality of life, and assesses its safety.See study design
What are the potential side effects?
Potential side effects from SABR may include skin reactions, fatigue, inflammation of treated organs depending on where the radiation is targeted (like lungs or liver), and other typical risks associated with radiation therapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
All my cancer areas can be safely targeted with radiation.
Select...
I am 18 years old or older.
Select...
I am able to get out of my bed or chair and move around.
Select...
My cancer has spread, and this was confirmed by tests.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ time from randomization to death from any cause, patients followed for 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time from randomization to death from any cause, patients followed for 5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Overall Survival
Secondary outcome measures
Progression-free survival
Quality of life- An individuals perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns.
Toxicity of Ablative Radiotherapy
Trial Design
2Treatment groups
Active Control
Group I: SABRActive Control1 Intervention
SABR to all tumors 6Gy x 5 over 3 weeks
Group II: Standard of CareActive Control1 Intervention
Standard or care palliative radiotherapy (includes the option for no treatment)
Find a Location
Who is running the clinical trial?
Lawson Health Research InstituteLead Sponsor
655 Previous Clinical Trials
413,201 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- All my cancer areas can be safely targeted with radiation.I am 18 years old or older.I am able to get out of my bed or chair and move around.My cancer has spread, and this was confirmed by tests.I have 11 or more cancer spots that can be treated, including the main tumor.
Research Study Groups:
This trial has the following groups:- Group 1: SABR
- Group 2: Standard of Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are people currently being recruited for this trial?
"The clinicaltrials.gov website reveals that this study is not currently recruiting patients. Although the trial was first posted on 2023-01-01, the most recent update was on 2022-08-17. There are 756 other trials that are actively recruiting patients."
Answered by AI
Share this study with friends
Copy Link
Messenger